The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

AHA Pitches Technology as a Lever to Cut Healthcare Costs

The American Hospital Association is making the case that technology is central to lowering healthcare costs. In a June 5 column, AHA President and CEO Rick Pollack argued that electronic health records and data-driven tools help clinicians spot problems earlier, eliminate duplicative testing, and coordinate treatment more effectively, according to Becker's Hospital Review.

The framing matters because it positions tech as an affordability play, not just a clinical or administrative one. Predictive analytics can flag patients at risk before they deteriorate, while shared records reduce the redundant labs and imaging that drive up bills. Better coordination, the AHA argues, means fewer gaps and less waste across a patient's care.

For hospital leaders, the message aligns with mounting pressure to show that large IT investments translate into real savings. The harder question is execution: realizing those gains depends on interoperability, clean data, and workflows that actually change clinician behavior. Pollack's column is as much advocacy as evidence, signaling how hospitals want to be seen amid scrutiny over costs.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.